KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 58 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,730,200 | -0.7% | 1,590,000 | 0.0% | 0.99% | +5.9% |
| Q1 2024 | $18,857,400 | -6.7% | 1,590,000 | -3.6% | 0.93% | -7.5% |
| Q4 2023 | $20,212,500 | +27.2% | 1,650,000 | 0.0% | 1.01% | +19.0% |
| Q3 2023 | $15,889,500 | +106900.0% | 1,650,000 | 0.0% | 0.85% | +22.8% |
| Q2 2023 | $14,850 | +14.5% | 1,650,000 | 0.0% | 0.69% | +8.2% |
| Q1 2023 | $12,969 | -99.6% | 1,650,000 | +725.0% | 0.64% | +216.9% |
| Q4 2019 | $3,562,000 | +53.5% | 200,000 | 0.0% | 0.20% | +19.6% |
| Q3 2019 | $2,320,000 | -47.6% | 200,000 | 0.0% | 0.17% | -55.9% |
| Q2 2019 | $4,430,000 | -22.6% | 200,000 | 0.0% | 0.38% | -42.4% |
| Q1 2019 | $5,724,000 | +44.9% | 200,000 | 0.0% | 0.66% | +35.7% |
| Q4 2018 | $3,950,000 | -10.7% | 200,000 | 0.0% | 0.49% | -0.6% |
| Q3 2018 | $4,422,000 | – | 200,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $13,155,000 | 11.03% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $2,974,000 | 3.14% |
| Vivo Capital, LLC | 1,476,796 | $11,297,000 | 1.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 227,433 | $1,731,000 | 0.79% |
| DAFNA Capital Management LLC | 234,952 | $1,797,000 | 0.75% |
| Samsara BioCapital, LLC | 168,174 | $1,287,000 | 0.74% |
| Ghost Tree Capital, LLC | 350,000 | $2,678,000 | 0.71% |
| Ikarian Capital, LLC | 946,605 | $7,242,000 | 0.54% |
| Opaleye Management Inc. | 225,000 | $1,721,000 | 0.46% |
| Eventide Asset Management | 1,680,000 | $12,852,000 | 0.42% |